Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rouyer

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
International Journal of Cancer|February 6, 1999
Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude miceJ J Maoret, Y Anini, C Rouyer-Fessard, et al.
Biochemical and Biophysical Research Communications|June 26, 1995
Mutational analysis of cysteine residues within the extracellular domains of the human vasoactive intestinal peptide (VIP) 1 receptor identifies seven mutants that are defective in VIP bindingP Gaudin, A Couvineau, J J Maoret, et al.
FEBS Letters|December 12, 1983
Interaction of Gila monster venom with VIP receptors in intestinal epithelium of human. A comparison with ratB Amiranoff, N Vauclin-Jacques, N Boige, et al.
Annals of the New York Academy of Sciences|February 3, 1999
Cloning and functional characterization of the human VIP1/PACAP receptor promoterA Couvineau, J J Maoret, C Rouyer-Fessard, et al.
Biochemical and Biophysical Research Communications|January 28, 1999
The human vasoactive intestinal Peptide/Pituitary adenylate cyclase activating peptide receptor 1 (VPAC1): constitutive activation by mutations at threonine 343P Gaudin, A Couvineau, C Rouyer-Fessard, et al.
Optics Letters|December 1, 2007
All-optical programmable shaping of narrow-band nanosecond pulses with picosecond accuracy by use of adapted chirps and quadratic nonlinearitiesX Ribeyre, C Rouyer, F Raoult, et al.
Medecine Et Maladies Infectieuses|December 2, 2017
Biphasic lung injury during Streptococcus pneumoniae infection in a murine modelA Prevotat, C Rouyer, P Gosset, et al.
Optics Express|June 17, 2009
3D numerical model for a focal plane view in case of mosaic grating compressor for high energy CPA chainS Montant, G Marre, N Blanchot, et al.
The Biochemical Journal|April 19, 2000
The human vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor 1 (VPAC1) promoter: characterization and role in receptor expression during enterocytic differentiation of the colon cancer cell line Caco-2Cl.20A Couvineau, J J Maoret, C Rouyer-Fessard, et al.
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie III, Sciences De La Vie|March 15, 1982
[Calmodulin regulation of intestinal epithelium adenylate cyclase (author's transl)]B Amiranoff, M Laburthe, C Rouyer-Fessard, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|February 6, 1999
Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude miceJ J Maoret, Y Anini, C Rouyer-Fessard, et al.
Biochemical and Biophysical Research Communications|June 26, 1995
Mutational analysis of cysteine residues within the extracellular domains of the human vasoactive intestinal peptide (VIP) 1 receptor identifies seven mutants that are defective in VIP bindingP Gaudin, A Couvineau, J J Maoret, et al.
FEBS Letters|December 12, 1983
Interaction of Gila monster venom with VIP receptors in intestinal epithelium of human. A comparison with ratB Amiranoff, N Vauclin-Jacques, N Boige, et al.
Annals of the New York Academy of Sciences|February 3, 1999
Cloning and functional characterization of the human VIP1/PACAP receptor promoterA Couvineau, J J Maoret, C Rouyer-Fessard, et al.
Biochemical and Biophysical Research Communications|January 28, 1999
The human vasoactive intestinal Peptide/Pituitary adenylate cyclase activating peptide receptor 1 (VPAC1): constitutive activation by mutations at threonine 343P Gaudin, A Couvineau, C Rouyer-Fessard, et al.
Optics Letters|December 1, 2007
All-optical programmable shaping of narrow-band nanosecond pulses with picosecond accuracy by use of adapted chirps and quadratic nonlinearitiesX Ribeyre, C Rouyer, F Raoult, et al.
Medecine Et Maladies Infectieuses|December 2, 2017
Biphasic lung injury during Streptococcus pneumoniae infection in a murine modelA Prevotat, C Rouyer, P Gosset, et al.
Optics Express|June 17, 2009
3D numerical model for a focal plane view in case of mosaic grating compressor for high energy CPA chainS Montant, G Marre, N Blanchot, et al.
The Biochemical Journal|April 19, 2000
The human vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor 1 (VPAC1) promoter: characterization and role in receptor expression during enterocytic differentiation of the colon cancer cell line Caco-2Cl.20A Couvineau, J J Maoret, C Rouyer-Fessard, et al.
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie III, Sciences De La Vie|March 15, 1982
[Calmodulin regulation of intestinal epithelium adenylate cyclase (author's transl)]B Amiranoff, M Laburthe, C Rouyer-Fessard, et al.
Pageof 7